|
|
|
Volumn 47, Issue 4, 1999, Pages 233-237
|
|
Pharmacologic treatment of type 2 diabetes mellitus: Realities and perspectives
a
a
a
RIZK HOSPITAL
(Lebanon)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACARBOSE;
ACETOHEXAMIDE;
ALPHA GLUCOSIDASE INHIBITOR;
BIGUANIDE;
CHLORPROPAMIDE;
GLIBENCLAMIDE;
GLIMEPIRIDE;
GLIPIZIDE;
GLUCOR;
GLUCOSE;
METFORMIN;
METFORMIN EMBONATE;
MIGLITOL;
REPAGLINIDE;
SULFONYLUREA DERIVATIVE;
TETRAHYDROLIPSTATIN;
THIAZOLIDINE DERIVATIVE;
TOLAZAMIDE;
TOLBUTAMIDE;
TROGLITAZONE;
UNCLASSIFIED DRUG;
BLOOD DYSCRASIA;
CARDIOVASCULAR DISEASE;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG ELIMINATION;
DRUG MECHANISM;
FOOD DRUG INTERACTION;
GASTROINTESTINAL SYMPTOM;
GLUCONEOGENESIS;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
LIVER TOXICITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
SKIN DISEASE;
ALGORITHMS;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
PATIENT COMPLIANCE;
TREATMENT OUTCOME;
|
|
EID: 0033369923
PISSN: 00239852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (51)
|
